日本京都京那霍尔巴已收购了Medtest Holdings,Canton,Mich,由Medtest DX,Pointe Scientific,Clinitox Diagnostix和医学实验室解决方案组成。

The acquisition will combine the complementary innovative technology offerings of the Horiba Medical segment with MedTest Dx technology, Clinitox, and Pointe Scientific’s research and development and manufacturing capabilities, with particular expertise in FDA 510K and CLIA clearances, to address the multidisciplinary requirements of IVD testing customers.

“我们的长期愿景和持续投资加上我们杰出的员工导致了创新的化学和免疫化技术解决方案,”Horiba董事长和集团首席执行官Atsushi Horiba说。“我非常高兴这种长期愿景导致了收购了Medtest。”

“Horiba Medical将通过其Yumizen品牌和当前的分销渠道继续提供创新的技术解决方案,”Horiba Medical Segment Leading Jai Hakhu,Horiba Instruments和法国Horiba Abx SAS总裁兼首席执行官博士兼首席执行官。

有关更多信息,请访问霍巴巴